Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Myelodysplastic Syndromes 2Multiple Myeloma 2Leukemia 2Infections 2Wilms Tumor 1Sarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neuroblastoma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mycoses 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Kidney Neoplasms 1Intraocular Lymphoma 1Immunologic Deficiency Syndromes 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1Hematologic Diseases 1Graft vs Host Disease 1

Interventions

plerixafor 2Voriconazole 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1B-Cell Activating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Immunologic Deficiency Syndromes × Voriconazole × Clear all
NCT00015665 2008-03-04

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
40 enrolled
Lymphoid

Immunologic Deficiency Syndromes, Infections, Lymphoma, Follicular, Mycoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡